Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo{1,2-g}-chrom-3-ene, benzo{1,2-g}-thiochrom-3-ene and benzo{1,2-g}-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type bi
A Standard patent application filed on 09 December 1997 credited to Vuligonda, Vidyasagar
;
Chandraratna, Roshantha A.
;
Johnson, Alan T
Details
Application number :
56929
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo{1,2-g}-chrom-3-ene, benzo{1,2-g}-thiochrom-3-ene and benzo{1,2-g}-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type bi
Inventor :
Vuligonda, Vidyasagar
;
Chandraratna, Roshantha A.
;
Johnson, Alan T
Agent name :
Davies Collison Cave
Address for service :
GPO Box 3876 SYDNEY NSW 2001
Filing date :
09 December 1997
Associated companies :
Applicant name :
Allergan, Inc.
Applicant address :
2525 Dupont Drive T-22-E Post Office Box 19534 Irvine CA 92623-9534 United States Of America